PREFER CHOICE METHODS
Online learnings to inform patients on choice elicitation tasks and assess patient preferences.
PREFER is a 5-year, IMI-funded, project that aims to investigate how and when patient preferences regarding the benefit/risk of drugs can be used in the medical product lifecycle. Multiple case studies use different choice elicitation tasks to investigate how these influence the preferences of patients. To support this research, MindBytes developed interactive educational tools to inform patients on these different methods and how to complete the preference surveys.
Benefits vs. risks
To discover these preferences efficiently, we were missing a structured approach. That is why many partners joined forces for the IMI-PREFER project. This project discovered what the key stakeholders think is important, based on literature review, interviews and focus group meetings with patient organisations, physicians, regulatory authorities, health technology assessment bodies, industry experts and academics.
This framework for patient preference studies has been explained in detail in the PREFER recommendations, which have received a positive qualification opinion from the European Medicines Agency (EMA) in 2022.
Methods for drug life cycle